🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a double-blind, placebo-controlled, parallel group design study wit...
Status
Terminated
Location
Boston University School of Medicine
Start Date
2009-05
Trial ID
NCT00862563
Treatments Being Tested
This is a 12-week study of levetiracetam added to a second generation antip...
Status
Completed
Location
NYU Langone Health
Start Date
2020-08-27
Trial ID
NCT04317807
Treatments Being Tested
This study plans to learn more about the effects of levetiracetam (LEV) on ...
Status
Completed
Location
Rocky Mountain Regional VA Medical Center, Aurora, CO
Start Date
2018-08-15
Trial ID
NCT03034356
Treatments Being Tested
The primary objectives of this study are to assess the efficacy of levetira...
Status
Completed
Location
Johns Hopkins School of Medicine
Start Date
2009-10
Trial ID
NCT00970814
Treatments Being Tested
The purpose of this study is to evaluate the effectiveness of Levetiracetam...
Status
Terminated
Location
Duke University Medical Center
Start Date
2005-11
Trial ID
NCT00299611
Treatments Being Tested
Levetiracetam (LEV: (S)-α-ethyl-2-oxo-pyrrolidine acetamide) is an anticonv...
Status
Completed
Location
University of Colorado Anschutz Medical Campus
Start Date
2013-06
Trial ID
NCT02647437
Treatments Being Tested
This randomized, crossover, placebo controlled clinical study will assess t...
Status
Recruiting
Location
Johns Hopkins University School of Medicine
Start Date
2025-04-17
Trial ID
NCT06919926
Prospective randomized double blind controlled trial in prevention of relap...
Status
Completed
Location
Klinikum Nürnberg Nord
Start Date
2007-05
Trial ID
NCT00758277
Treatments Being Tested
The purpose of this study is to test whether administration of levetiraceta...
Status
Completed
Location
Vanderbilt University Medical Center
Start Date
2020-09-23
Trial ID
NCT04559529
Treatments Being Tested